
1. arch intern med. 1990 oct;150(10):2167-8.

spontaneous pneumothorax patients acquired immunodeficiency syndrome
treated prophylactic aerosolized pentamidine.

newsome gs(1), ward dj, pierce pf.

author information: 
(1)georgetown university medical center, washington, dc 20007.

spontaneous pneumothorax known complication pneumocystis carinii
pneumonia patients acquired immunodeficiency syndrome. evaluate
the possible pathogenesis natural history pneumothorax patients
receiving aerosolized pentamidine prophylaxis, retrospectively reviewed 327
outpatients positive human immunodeficiency virus receiving aerosolized
pentamidine. 12 spontaneous pneumothoraces group patients. 
seventy-five percent patients pneumothorax roentgenographic evidence 
of fibrocystic lung parenchyma clinical evidence active pneumocystis
pneumonia. majority (83%) required chest tube evacuation. 50%
mortality rate associated complication. findings suggest that
spontaneous pneumothorax patients treated aerosolized pentamidine most
commonly represents prophylaxis failure associated high mortality rate.


pmid: 2222102  [indexed medline]

